Literature DB >> 35499646

Propensity-Matched Analysis of the Short-Term Outcome of Robot-Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer.

Takeo Fujita1, Kazuma Sato2, Asako Ozaki2, Tomohiro Akutsu2, Hisashi Fujiwara2, Takashi Kojima3, Hiroyuki Daiko4.   

Abstract

BACKGROUND: In this matched-cohort study, we investigated the short-term outcome of robot-assisted minimally invasive esophagectomy (RAMIE) compared with conventional minimally invasive thoracoscopic esophagectomy (MIE) in esophageal cancer patients.
METHODS: One hundred eighty-nine patients with thoracic esophageal cancer scheduled to undergo thoracic esophagectomy between 2020 and 2021 were assigned to either RAMIE or MIE. Then, we retrospectively evaluated the postoperative surgical complications between two groups in a propensity-matched analyzation.
RESULTS: Based on the propensity-matched score, 50 patients who underwent RAMIE or MIE were selected. Thoracic surgery time in RAMIE/MIE group were 233.1/173.3 min (p < 0.01), respectively. No significant intergroup differences were observed regarding incisional anastomotic leakage (RAMIE group 4.0% vs. MIE group 6.0%) and pneumonia (RAMIE group 8.0% vs. MIE group 12.0%; p = 0.68). The respective incidences of recurrent laryngeal nerve paralysis were 34.0 and 8.0% in the MIE and RAMIE groups, respectively (p < 0.01). In the matched cohort, no differences were observed between the groups in the success accomplishment of the clinical management pathway (RAMIE group 94.0% vs. MIE group 88.0%).
CONCLUSIONS: Although patients who underwent RAMIE had longer operation times, the incidence of recurrent laryngeal nerve paralysis was lower than with MIE. Further study in a prospective multi-institutional setting are required to confirm the superiority of RAMIE compared with MIE.
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2022        PMID: 35499646     DOI: 10.1007/s00268-022-06567-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  13 in total

1.  A standardized approach for the thoracic dissection in robotic-assisted minimally invasive esophagectomy (RAMIE).

Authors:  B F Kingma; M Read; R van Hillegersberg; Y K Chao; J P Ruurda
Journal:  Dis Esophagus       Date:  2020-11-26       Impact factor: 3.429

2.  Response to: Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".

Authors:  Zhonghu He; Fangfang Liu; Wenlei Yang; Yang Ke
Journal:  Ann Surg       Date:  2021-11-09       Impact factor: 12.969

3.  Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.

Authors:  Tomoki Abe; Taro Oshikiri; Hironobu Goto; Takashi Kato; Manabu Horikawa; Ryuichiro Sawada; Hitoshi Harada; Naoki Urakawa; Hiroshi Hasegawa; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Yoshihiro Kakeji
Journal:  Ann Surg Oncol       Date:  2021-11-22       Impact factor: 5.344

4.  Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study.

Authors:  Glauco Baiocchi; Reitan Ribeiro; Ricardo Dos Reis; Deraldo Fernando Falcao; Andre Lopes; Ronaldo Lucio Rangel Costa; Gabriel Lowndes Souza Pinto; Marcelo Vieira; Lillian Yuri Kumagai; Carlos Chaves Faloppa; Henrique Mantoan; Levon Badiglian-Filho; Audrey Tieko Tsunoda; Tariane Friedrich Foiato; Carlos Eduardo Mattos Cunha Andrade; Leonardo Oliveira Palmeira; Bruna Tirapelli Gonçalves; Paulo Henrique Zanvettor
Journal:  Ann Surg Oncol       Date:  2021-09-20       Impact factor: 5.344

5.  Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis.

Authors:  David T Pointer; Sabrina Saeed; Samer A Naffouje; Rutika Mehta; Sarah E Hoffe; Sean P Dineen; Jason B Fleming; Jacques P Fontaine; Jose M Pimiento
Journal:  Ann Surg       Date:  2020-11-16       Impact factor: 13.787

6.  Robotic minimally invasive esophagectomy provides superior surgical resection.

Authors:  Ahmed M Ali; Katelynn C Bachman; Stephanie G Worrell; Kelsey E Gray; Yaron Perry; Philip A Linden; Christopher W Towe
Journal:  Surg Endosc       Date:  2020-11-10       Impact factor: 4.584

7.  Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety.

Authors:  Ioannis T Konstantinidis; Philip Ituarte; Yanghee Woo; Susanne G Warner; Kurt Melstrom; Jae Kim; Gagandeep Singh; Byrne Lee; Yuman Fong; Laleh G Melstrom
Journal:  Surg Endosc       Date:  2019-12-09       Impact factor: 4.584

8.  Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis.

Authors:  Cristian A Angeramo; Camila Bras Harriott; María A Casas; Francisco Schlottmann
Journal:  Surgery       Date:  2021-08-11       Impact factor: 3.982

Review 9.  The potential for reducing alcohol consumption to prevent esophageal cancer morbidity in Asian heavy drinkers: a systematic review and meta-analysis.

Authors:  Yuto Kubo; Yuko Kitagawa; Tatsuya Miyazaki; Makoto Sohda; Taiki Yamaji; Makoto Sakai; Hiroshi Saeki; Kenji Nemoto; Tsuneo Oyama; Manabu Muto; Hiroya Takeuchi; Yasushi Toh; Hisahiro Matsubara; Masayuki Mano; Koji Kono; Ken Kato; Masahiro Yoshida; Hirofumi Kawakubo; Eisuke Booka; Tomoki Yamatsuji; Hiroyuki Kato; Yoshinori Ito; Hitoshi Ishikawa; Ryu Ishihara; Takahiro Tsushima; Hiroshi Kawachi; Takashi Oyama; Takashi Kojima; Shiko Kuribayashi; Tomoki Makino; Satoru Matsuda; Yuichiro Doki
Journal:  Esophagus       Date:  2021-10-24       Impact factor: 4.230

View more
  1 in total

Review 1.  Features and applications of energy devices for prone robot-assisted minimally invasive esophagectomy: a narrative review.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Hikota Hayashi; Yoshitsugu Tajima
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.